Frontlight ResearchEarly access
Taking peopleNo phase
INTERACT4 Expansion - Validation Study
Key facts
- Who runs it
- The George Institute
- Where
- Australia6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 163 people, planned
- Started
- 18 Sept 2026
- Expected to end
- 1 Jun 2027
- Type of study
- Observational
- Treatments tested
- LVOne
- Record updated
- 26 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adults (age ≥18 years)
- Acute syndrome that is due to presumed acute stroke, defined as FAST (Face, Arm, Speech, Time) scores of ≥2 with an arm motor deficit
- Time ≤3 hours from last seen well
- Systolic BP (SBP) ≥150mmHg
Who cannot take part
- Severe known co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability [needing help])
- Known history of epilepsy or seizure at onset
- Recent head injury (where there is potential for another type of intracranial haemorrhage or head trauma)
- Hypoglycaemia (glucose<4.0 mmol/L) as measured in the ambulance
- Participants in coma (no response to tactile/verbal stimulation); or/and do not respond to "P" or "U" on the alert/verbal/painful/unresponsive (APVU) responsiveness scale
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the feasibility of setting up and conducting a trial that uses a point-of-care GFAP test to identify ICH in patients presenting with acute stroke-like symptoms in the pre-hospital setting.
Treatments tested
- LVOne
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
- Record updated
- 26 October 2026